Last update 08 May 2025

WIZ x ZBTB7A x CRBN

Basic Info

Related Targets
WIZZBTB7ACRBN

Related

1
Drugs associated with WIZ x ZBTB7A x CRBN
BMS-986470
Target
CRBN x WIZ x ZBTB7A
Mechanism
CRBN modulators [+2]
Active Org.
Bristol Myers Squibb Co.Bristol Myers Squibb Co.
Originator Org.
Bristol Myers Squibb Co.Bristol Myers Squibb Co.
Active Indication
Anemia, Sickle Cell
Inactive Indication-
Drug Highest PhasePhase 1/2
First Approval Ctry. / Loc.-
First Approval Date20 Jan 1800
1
Clinical Trials associated with WIZ x ZBTB7A x CRBN
NCT06481306
/ RecruitingPhase 1/2
A Phase 1/2a, First-in-human, Randomized, Double-blinded, Placebo-controlled, Dose-finding Study in Healthy Volunteers and Participants With Sickle Cell Disease to Evaluate the Safety and Tolerability, Pharmacokinetics, Pharmacodynamics, pH and Food Effect, and Preliminary Efficacy of BMS-986470
100 Clinical Results associated with WIZ x ZBTB7A x CRBN
Login to view more data
100 Translational Medicine associated with WIZ x ZBTB7A x CRBN
Login to view more data
0 Patents (Medical) associated with WIZ x ZBTB7A x CRBN
Login to view more data

Analysis

Perform a panoramic analysis of this field.
login
or
view full example data
Perform a panoramic analysis of this field.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free